Breast Cancer changes everything – your perspectives, your expectations and a lot of women discover the inner resolve and resilience that they never knew they had, to brace up to fight and even beat the cancer.
Welcome to the most detailed page on breast cancer treatments and research. We have accumulated easy to understand treatment results from various clinical trials across the world.
We have over 5 dozen approved breast cancer treatment documented and explained in a simple way and interlaced with over 100 result revealing charts and videos revealing important facets of treatment.
Let us explore some key facts – some of which we are sure will give you hope.
- Breast cancer treatment have come a long way. Today, more women are surviving this disease than ever before.
- More than 80% of women survive 5 years or more compared to 50% 4 decades back. When the cancer is detected early, the 5 year survival and cure rate is much higher – more than 90%.
- Unfortunately in women whose cancer is detected at a very advanced stage where the cancer has spread to vital organs – the 5 year survival statistic is only 15%.
- In the last decade mortality rates have fallen by 20%. It is expected to further improve in the next 10 years.
- 75% of women diagnosed with breast cancer survive for 10 years or more. 66% of women survive 20 years or more. In a lot of women who go into remission, the cancer doesnt come back and they live normal healthy lives.
Breast Cancer Clinical Studies
The following data is meant to offer a simple understanding of the various clinical trials and how the patients responded to the various treatments. Most of the clinical studies on this page are of approved medications in use currently although rarely you will find the odd experimental study.
Note: Breast cancer is one of the more treatable cancers unless it is diagnosed at a very advanced stage. The prognosis is encouraging as explained above – however please note that there are quite a few treatment results listed in the following sections where in advanced stage – the survival rate is poor. This is mostly because of 2 reasons and you should know so as to not be unnerved.
Firstly, the poor results depicted are usually when the cancer has gone metastatic – Secondly – the overall survival period, which is often referred to in clinical trial terminology, does not take into account the patients that were lost to followup.
Not just that, the patients that survived the full period of the study are also not taken into account. Only patients who met death are included for the statistic called ‘Overall Survival”. This in our opinion skews the statistic. We just want you to know this upfront. Pl keep this in mind while viewing the studies on advanced breast cancer.